CEO and Medical Director, Urology Cancer Center and GU Research Network
Oncology
Dr. Luke T. Nordquist, MD
|
|
Give Review
Dr. Luke T. Nordquist works in the field of Oncology. He went to medical school at Creighton University School of Medicine. Creighton University School of Medicine is ranked 79/78 in Research/PrimaryCare. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "QOPI Certification". Luke Nordquist has written publications. He has 8 publications published with PubMed. The lastest paper is: 'Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer.
- Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung.
- DNA vaccines: an active immunization strategy for prostate cancer.
- Octreotide for gastrointestinal bleeding of obscure origin in an anticoagulated patient.
- [American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer].
- American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer.
- Rapid androgen cycling as treatment for patients with prostate cancer.
Schools
Creighton University School Of Medicine
HLee Moffitt Cancer CenterUniversity Of South Florida
Memorial Sloan Kettering Cancer Center
Creighton University
Procedures Preformed
- Radiation Oncology Procedures
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- QOPI Certification
Education
-
Memorial Sloan-Kettering Cancer Center -
University of South Florida -
Creighton University School of Medicine
Drug Facts
| NPI NUMBER | 1538149414 | |
| NPPES Provider LastName | NORDQUIST | |
| NPPES Provider FirstName | LUKE | |
| NPPES Provider ZIPCode | 681242372 | |
| NPPES Provider State | NE | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 487.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1538149414 |
| Last Name Of The Provider | NORDQUIST |
| First Name Of The Provider | LUKE |
| View All |
Similar Doctors
|
Dr. Lyudmyla Berim, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Susan M. Constantino, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Elizabeth C. Reed, MD |
|
|
Dr. Nicole A. Shonka, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Stephen J. Lemon, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Alissa S. Marr, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Timothy K. Huyck, MD
This Doctor is OpenDoctor Recommended.
|